vs

Side-by-side financial comparison of Pulmonx Corp (LUNG) and Rumble Inc. (RUM). Click either name above to swap in a different company.

Rumble Inc. is the larger business by last-quarter revenue ($27.1M vs $20.6M, roughly 1.3× Pulmonx Corp). Pulmonx Corp runs the higher net margin — -66.3% vs -120.8%, a 54.5% gap on every dollar of revenue. On growth, Pulmonx Corp posted the faster year-over-year revenue change (-8.7% vs -10.5%). Over the past eight quarters, Rumble Inc.'s revenue compounded faster (15.2% CAGR vs -0.5%).

Pulmonx Corp is a global medical tech firm focused on interventional pulmonology solutions. It develops minimally invasive endobronchial valves to treat severe COPD and emphysema, with products sold across North America, Europe, and Asia-Pacific for patients with advanced lung conditions.

Rumble is a Canadian-American online video platform, web hosting, and cloud services business headquartered in Toronto, Canada, with its U.S. headquarters in Longboat Key, Florida. It was founded in 2013 by Chris Pavlovski, a Canadian technology entrepreneur. Rumble's cloud services business hosts Truth Social, and the video platform is popular among American conservative and far-right users. Rumble has been described as "alt-tech".

LUNG vs RUM — Head-to-Head

Bigger by revenue
RUM
RUM
1.3× larger
RUM
$27.1M
$20.6M
LUNG
Growing faster (revenue YoY)
LUNG
LUNG
+1.8% gap
LUNG
-8.7%
-10.5%
RUM
Higher net margin
LUNG
LUNG
54.5% more per $
LUNG
-66.3%
-120.8%
RUM
Faster 2-yr revenue CAGR
RUM
RUM
Annualised
RUM
15.2%
-0.5%
LUNG

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
LUNG
LUNG
RUM
RUM
Revenue
$20.6M
$27.1M
Net Profit
$-13.7M
$-32.7M
Gross Margin
77.9%
5.5%
Operating Margin
-40.9%
-131.1%
Net Margin
-66.3%
-120.8%
Revenue YoY
-8.7%
-10.5%
Net Profit YoY
5.5%
86.2%
EPS (diluted)
$-0.33
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LUNG
LUNG
RUM
RUM
Q1 26
$20.6M
Q4 25
$22.6M
$27.1M
Q3 25
$21.5M
$24.8M
Q2 25
$23.9M
Q1 25
$22.5M
$23.7M
Q4 24
$23.8M
$30.2M
Q3 24
$20.4M
$25.1M
Q2 24
$20.8M
$22.5M
Net Profit
LUNG
LUNG
RUM
RUM
Q1 26
$-13.7M
Q4 25
$-10.4M
$-32.7M
Q3 25
$-14.0M
$-16.3M
Q2 25
$-15.2M
Q1 25
$-14.4M
$-2.7M
Q4 24
$-13.2M
$-236.8M
Q3 24
$-14.1M
$-31.5M
Q2 24
$-15.3M
$-26.8M
Gross Margin
LUNG
LUNG
RUM
RUM
Q1 26
77.9%
Q4 25
77.6%
5.5%
Q3 25
74.7%
-1.8%
Q2 25
72.1%
Q1 25
72.5%
-26.7%
Q4 24
74.0%
-14.2%
Q3 24
73.7%
-45.4%
Q2 24
73.7%
-58.8%
Operating Margin
LUNG
LUNG
RUM
RUM
Q1 26
-40.9%
Q4 25
-43.8%
-131.1%
Q3 25
-66.9%
-113.6%
Q2 25
-62.0%
Q1 25
-64.6%
-153.5%
Q4 24
-56.5%
-80.1%
Q3 24
-69.3%
-131.0%
Q2 24
-75.2%
-172.7%
Net Margin
LUNG
LUNG
RUM
RUM
Q1 26
-66.3%
Q4 25
-46.1%
-120.8%
Q3 25
-64.9%
-65.7%
Q2 25
-63.6%
Q1 25
-64.1%
-11.2%
Q4 24
-55.4%
-783.2%
Q3 24
-69.4%
-125.9%
Q2 24
-73.7%
-119.2%
EPS (diluted)
LUNG
LUNG
RUM
RUM
Q1 26
$-0.33
Q4 25
$-0.25
$-0.13
Q3 25
$-0.34
$-0.06
Q2 25
$-0.38
Q1 25
$-0.36
$-0.01
Q4 24
$-0.33
$-1.17
Q3 24
$-0.36
$-0.15
Q2 24
$-0.39
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LUNG
LUNG
RUM
RUM
Cash + ST InvestmentsLiquidity on hand
$61.6M
$237.9M
Total DebtLower is stronger
$37.3M
Stockholders' EquityBook value
$45.8M
$274.8M
Total Assets
$120.0M
$336.8M
Debt / EquityLower = less leverage
0.82×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LUNG
LUNG
RUM
RUM
Q1 26
$61.6M
Q4 25
$69.8M
$237.9M
Q3 25
$76.5M
$269.8M
Q2 25
$75.5M
Q1 25
$74.6M
$301.3M
Q4 24
$70.9M
$114.0M
Q3 24
$63.3M
$132.0M
Q2 24
$63.5M
$154.2M
Total Debt
LUNG
LUNG
RUM
RUM
Q1 26
$37.3M
Q4 25
$37.1M
Q3 25
$37.1M
Q2 25
$37.1M
Q1 25
$37.2M
Q4 24
$37.2M
Q3 24
$37.2M
Q2 24
$37.2M
Stockholders' Equity
LUNG
LUNG
RUM
RUM
Q1 26
$45.8M
Q4 25
$54.1M
$274.8M
Q3 25
$60.0M
$302.2M
Q2 25
$69.1M
Q1 25
$77.7M
$339.6M
Q4 24
$85.8M
$-63.1M
Q3 24
$93.9M
$166.1M
Q2 24
$101.2M
$192.7M
Total Assets
LUNG
LUNG
RUM
RUM
Q1 26
$120.0M
Q4 25
$129.3M
$336.8M
Q3 25
$138.3M
$367.2M
Q2 25
$147.2M
Q1 25
$150.7M
$391.1M
Q4 24
$162.8M
$195.3M
Q3 24
$167.4M
$217.2M
Q2 24
$172.6M
$243.2M
Debt / Equity
LUNG
LUNG
RUM
RUM
Q1 26
0.82×
Q4 25
0.69×
Q3 25
0.62×
Q2 25
0.54×
Q1 25
0.48×
Q4 24
0.43×
Q3 24
0.40×
Q2 24
0.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LUNG
LUNG
RUM
RUM
Operating Cash FlowLast quarter
$-29.4M
Free Cash FlowOCF − Capex
$-31.7M
FCF MarginFCF / Revenue
-117.2%
Capex IntensityCapex / Revenue
8.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-70.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LUNG
LUNG
RUM
RUM
Q1 26
Q4 25
$-7.1M
$-29.4M
Q3 25
$-8.2M
$-10.6M
Q2 25
$-3.9M
Q1 25
$-13.2M
$-14.5M
Q4 24
$-6.7M
$-12.4M
Q3 24
$-7.2M
$-19.1M
Q2 24
$-5.8M
$-21.7M
Free Cash Flow
LUNG
LUNG
RUM
RUM
Q1 26
Q4 25
$-7.1M
$-31.7M
Q3 25
$-8.3M
$-12.0M
Q2 25
$-4.0M
Q1 25
$-13.5M
$-14.6M
Q4 24
$-6.8M
$-12.4M
Q3 24
$-7.7M
$-19.9M
Q2 24
$-6.2M
$-23.1M
FCF Margin
LUNG
LUNG
RUM
RUM
Q1 26
Q4 25
-31.4%
-117.2%
Q3 25
-38.4%
-48.6%
Q2 25
-16.6%
Q1 25
-60.0%
-61.7%
Q4 24
-28.8%
-40.9%
Q3 24
-37.6%
-79.5%
Q2 24
-30.0%
-102.8%
Capex Intensity
LUNG
LUNG
RUM
RUM
Q1 26
Q4 25
0.1%
8.5%
Q3 25
0.4%
5.7%
Q2 25
0.2%
Q1 25
1.3%
0.6%
Q4 24
0.5%
0.1%
Q3 24
2.0%
3.4%
Q2 24
2.3%
6.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LUNG
LUNG

Segment breakdown not available.

RUM
RUM

Audience Monetization$23.8M88%
Other Initiatives$3.3M12%

Related Comparisons